期刊文献+

重症肌无力合并甲状腺功能亢进外周血T淋巴细胞Fas表达研究 被引量:5

Expression of fas antigen in peripheral blood T lymphocytes in patients with myasthenia gravis complicating with hyperthyroidism
原文传递
导出
摘要 目的探讨Fas介导的细胞凋亡与重症肌无力(MG)合并甲状腺功能亢进(甲亢)机制的关系。方法对2007年10月至2009年12月中山大学附属第五医院收治的17例MG患者及13名健康对照者进行研究,采用流式细胞技术检测外周血T淋巴细胞表面CD4、CD8及Fas的表达。结果合并甲亢的MG患者(5例)中眼肌型MG比例高于无合并甲亢MG组(40.0%对16.7%),胸腺增生及胸腺瘤的发生率均比无合并甲亢MG组低(前者20%对50%;后者0对25%),但差异无统计学意义。合并甲亢MG组患者外周血T淋巴细胞中CD4+CD8-细胞比例比对照组高(P=0.034)。合并甲亢MG组外周血T淋巴细胞中CD4+Fas+、CD4+CD8+Fas+细胞比例比对照组高,CD4+CD8+Fas+细胞比例比无合并甲亢MG组高,差异有统计学意义(均P<0.05)。结论甲亢在MG中发生率较高;合并甲亢的MG患者外周血CD4+T淋巴细胞中Fas的表达升高,可能与MG合并甲亢的发病机制有关。 Objective To investigate the correlation between Fas-mediated apoptosis and the pathogenesis of myasthenia gravis (MG) complicating with hyperthyoidism. Methods A total of 17 patients with MG and 13 normal controls were enrolled from The Fifth Affiliated Hospital of Sun Yat-sen University between October 2007 and December 2009. Expressions of cellular surface CD4, CD8 and Fas in peripheral blood T lymphocyte were analyzed via flow cytometry. Results Of 5 pa- tients with MG who had hyperthyroidism, prevalence of ocular MG was higher than those who had MG without hyperthyroidism (40.0% vs 16.7% ),and by contrast, lower prevalence of thyroid hyperplasia and thymoma was associated with patients who had MG without hyperthyroidism (thyroid hyperplasia:20% vs 50% ;thymoma:0 vs 25 %, both P 〉 0.05 ). Patients with MG complicating with hyperthyroidism yielded a higher proportion of peripheral blood CD4 + CD8 - cells as compared with normal controls ( P = 0. 034 ). Additionally, as compared with that of controls, a higher proportion of peripheral blood CD4 ^+ Fas^+ and CD4 + CD8 ^+ Fas^+ cells was found in patients who had MG complicating with hyperthyroidism ( both P 〈 0. 05 ). These patients were found to present higher proportion of peripheral CD4 ^+ CD8 ^+Fas^ + than those who had MG without hyperthyroidism ( P 〈 0. 05 ). Conclusion Higher prevalence of hyperthyroidism is associated in patients with MG. Up-regulated expression of Fas antigen in peripheral blood CD4^ + T lymphocytes in patients who had MG complicating with hyperthyroidism may be correlated with the pathogenesis.
出处 《中国实用内科杂志》 CAS CSCD 北大核心 2012年第5期360-362,共3页 Chinese Journal of Practical Internal Medicine
基金 广东省卫生厅医学科研基金(B2007079)
关键词 重症肌无力 甲状腺功能亢进 FAS抗原 T淋巴细胞亚群 myasthenia gravis hyperthyroidism fas antigen T lymphocyte subsets
  • 相关文献

参考文献15

  • 1Trabelsi L, Charfi N, Triki Ch, et al. Myasthenia gravis and hyper- thyroidism:two cases[ J]. Ann Endocrinol (Paris) ,2006,67:265 - 269.
  • 2Koves IH, Cameron FJ, Kornberg AJ. Ocular myasthenia gravis and Graves disease in a 10-year-old child[ J]. J Child Neurol,2009,24 (5) :615 -617.
  • 3Nakamura H, Usa T, Motomura M, et al. Prevalence of interrelated autoantibodies in thyroid diseases and autoimmune disorders [ J ]. J Endocrinol Invest ,2008,31 : 861 - 865.
  • 4Sekiguchi Y, Hara Y, Takahashi M, et al. Reverse ' see-saw' rela- tionship between Graves' disease and myasthenia gravis;clinical and immunological studies[ J].J Med Dent Sci ,2005,52:43 -50.
  • 5熊小平,任明山,杨毅,许文华,王晓秋.鼻粘膜耐受对实验性重症肌无力大鼠胸腺Fas、BCL-2表达的影响[J].中国神经精神疾病杂志,2009,35(1):11-14. 被引量:5
  • 6Aruna BV, Ben-David H, Sela M, et al. A dual altered peptide lig- and down-regulates myasthenogenic T cell responses and reverses experimental autoimmune myasthenia gravis via up-regulation of Fas-FasL-mediated apoptosis [ J ]. Immunology, 2006, 118 ( 3 ) : 413 -424.
  • 7Fountoulakis S, Vartholomatos G, Kolaitis N, et al. Differential. ex- pression of Fas system apoptotic molecules in peripheral lymphocytes from patients with Graves' disease and Hashimoto's thyroiditis [ J ]. Eur J Endocrino1,2008,158:853 - 859.
  • 8Bossowski A, Czarnocka B, Bardadin K, et al. Identification of apop- totic proteins in thyroid gland from patients with Graves' disease and Hashimoto's thyroiditis [ J ]. Autoimmunity ,2008 ,41 : 163 - 173.
  • 9Conti-Fine BM, Milani M, Kaminski HJ. Myasthenia gravis : past, present, and future [ J ]. J Clin Invest,2006,116 ( 11 ) :2843 - 2854.
  • 10Marino M, Ricciardi R, Pinchera A, et al. Mild clinical expression of myasthenia gravis associated with autoimmune thyroid diseases [ J ]. J Clin Endocrinol Metab, 1997,82:438 - 443.

二级参考文献27

  • 1赖成虹,李作孝.Fas和Bcl-2与重症肌无力[J].医学综述,2005,11(2):153-154. 被引量:6
  • 2许文华,韩莹莹,汪思应,任明山.鼠源乙酰胆碱受体α亚基97-116肽段免疫Lewis鼠诱导实验性重症肌无力模型[J].中国神经精神疾病杂志,2006,32(2):179-180. 被引量:40
  • 3魏雪飞,许贤豪,胡文立.重症肌无力患者胸腺凋亡基因Bcl-2和Fas的表达水平与临床的相关性[J].临床神经病学杂志,2006,19(5):321-323. 被引量:5
  • 4Levinson AI, Wheatley LM. The thymus and the pathogenesis of myasthenia gravis [ J ]. Clin Immunol Immunopathol, 1996, 78 (1):1 -5.
  • 5Lennon VA, Lindstrom JM, Seybold ME. Experimental autoimmune myasthenia: A model of myasthenia gravis in rats and guineapigs [J]. Exp Med,1975,141 (6) :1365 - 1375.
  • 6Baggi F, Annoni A, Ubiali F, et al. Breakdown of tolerance to a self-peptide of acetyleholine receptor alpha-subunit induces experimental myasthenia gravis in rats [ J ]. Immunol, 2004,172 ( 4 ) : 2697 - 2670.
  • 7Cohen PL, Eisenberq RA. Lpr and gld:single gene model of systemic autoimmunity and lymphoroliferative disease [ J ]. Annu Rev Immunol, 1991,9:243 - 269.
  • 8Shiono H, Fujii Y, Okumura M, et al. Failure to down-regulate Bcl- 2 protein in thymic germinal center B cells in myasthenia gravis [ J ]. Eur J Immunol, 1997,27 (4) :805 - 809.
  • 9Arena BV,Ben-David H,Sela M,et al. A dual altered pe-ptide ligand down-regulates myasthenogenic T cell Responses and reverses e-xpermintal autoimmune m-yasthenia gravis via up-regulation of Fas-FasL-mediatedapoptosis [ J]. Immunol,2006,166 ( 5 ) :3458 - 3467.
  • 10Draehman DB, Wu JM, Miagkov A, et al. Specific immunetherapy of experimental myasthenia by genetically e-ngineered APCs: the "guided missile" strategy[ J]. Ann NY Acad Sei ,2003,998 ( 1 ) : 520 - 532.

共引文献15

同被引文献60

引证文献5

二级引证文献26

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部